发明名称 New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them
摘要 <p>Dihydro-oxazolobenzodiazepinone derivatives (I) are new. Dihydro-oxazolobenzodiazepinone derivatives of formula (I) and their positional isomers, enantiomers, diastereoisomers or addition salts with acids, solvates, complexes or adducts, are new. R1 : H or 1-4C alkyl; R2 : 1-4C alkyl; and R3 : (hetero)aryl. An independent claim is included for the preparation of (I). [Image] ACTIVITY : Neuroleptic; Antidepressant; Neuroprotective; Nootropic; Antiparkinsonian; Anticonvulsant; Tranquilizer; Vulnerary; Cerebroprotective. MECHANISM OF ACTION : gamma -Aminobutyric acid (GABA) receptor agonist. The GABA receptor agonistic activity of (I) was tested in human embryonic kidney (HEK-293) cells. The result showed that 5-(6-fluoro-1-benzothien-2-yl)-8-methyl-1,9-dihydro-2H-[1,3]oxazolo[4,5-h][2,3]benzodiazepin-2-one exhibited an IC 5 0value of 100 nM.</p>
申请公布号 AP3344(A) 申请公布日期 2015.07.31
申请号 AP20120006149 申请日期 2012.03.06
申请人 LES LABORATOIRES SERVIER;EGIS GYOGYSZERGYAR NYRT 发明人 SPEDDING MICHAEL;ANTONI FERENC;HARSING LASZLO
分类号 A61K31/551;C07D498/04 主分类号 A61K31/551
代理机构 代理人
主权项
地址
您可能感兴趣的专利